Encellin
San Francisco, US · Founded 2015 · Delaware corporation · 8 known investors
Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr. Tejal Desai's laboratory at UCSF that combines micro and nanotechnologies with novel drug delivery approaches. The company focuses on therapeutic delivery platforms and cell-based treatments, particularly for diseases including diabetes and autoimmune conditions.
Founders & leadership
TD
Tejal DesaiTechnology Expert, Founder
RM
Ronald MartellStrategic Advisor, Founder
CN

Crystal NyitrayExecutive Officer, Director, Promoter
GW

Grace WeiExecutive Officer, Director, Promoter
MD
Maria del Consuelo ValverdeDirector
Investors · 8
Reported raises · per SEC filings
Form D private placements▶$9.9MraisedDec 2023 · 26 investors · OtherRule 506(b)
▶$9.9MraisedDec 2023 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Crystal NyitrayExecutive Officer, Director
- Maria del Consuelo ValverdeDirector
- Grace WeiDirector
- Offering amount
- $9.9M
- Amount sold
- $9.9M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJul 2019 · 7 investors · OtherRule 506(b)
▶$2.1MraisedJul 2019 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Crystal NyitrayExecutive Officer, Director, Promoter
- Grace WeiExecutive Officer, Director, Promoter
- Ronald MartellExecutive Officer, Director
- Maria del Consuelo ValverdeDirector
- Offering amount
- $2.7M
- Amount sold
- $2.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Encellin: $9.9 Million Raised To Pioneer Living Medicine Platformspulse2.com · 2023
- Encellin raises about $10M for type 1 diabetes cell replacement therapy — Encellinencellin.com · 2023
- Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disordersbusinesswire.com · 2023
- Encellin Raises $9.9M in Fundingfinsmes.com · 2023
- Grace Wei’s Journey from Academia to Encellin Co-Founder and Entrepreneur — Encellinencellin.com · 2020